Adenosine receptor signaling in vascular diseases: from molecular mechanisms to targeted therapeutics

ACTA PHARMACOLOGICA SINICA · Published 2026-06-26 · DOI 10.1038/s41401-026-01854-1

Free full text

Authors (4)

De-hua Yang, Jiao-jiao Wang, Yu-qing Huo, Zhi-ping Liu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Yang, D., Wang, J., Huo, Y., et al. (2026). Adenosine receptor signaling in vascular diseases: from molecular mechanisms to targeted therapeutics. ACTA PHARMACOLOGICA SINICA. https://doi.org/10.1038/s41401-026-01854-1

Related articles

• Macrophage FOLR2 drives liver fibrosis via intercellular engagement of TGFβRII · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• Cardiomyocyte OTUD7b drives diabetic cardiomyopathy via deubiquitinating and stabilizing TAK1 · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• Astrocytic adrenergic α2 receptor contributes to the mechanisms underlying the circadian rhythmicity of seizure susceptibility · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• The solute carrier transporter SLCO5A1 as a novel therapeutic target for the treatment of myocardial infarction-induced heart failure · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• Serum/glucocorticoid-regulated kinase 1 regulates vascular inflammation in atherosclerosis · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• METTL3 loss exacerbates colitis via m6A-dependent Slc39a8 regulation and epithelial lineage depletion · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• Secreted chimeric proteins as a strategy to correct SOX17 deficiency and attenuate the malignant phenotype of cholangiocarcinoma cells: a proof-of-concept study · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• Activation of peripheral muscarinic receptors rescues depressive-like behaviors via gut-brain-axis, involving parasympathetic excitation · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• Molecular mechanisms for sustaining cancer stem cells characteristics and targeted therapeutic strategies · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal
• Structural basis for dual targeting of μ-opioid and nociceptin/orphanin FQ receptors by Cebranopadol · ACTA PHARMACOLOGICA SINICA · 2026 · Same journal